What Is Menin and Can Restoring This Brain Protein Actually Reverse Skin Aging?

Menin is a scaffold protein encoded by the MEN1 gene that acts as a key suppressor of inflammatory signaling in the hypothalamus — the small brain region coordinating metabolism, hormones, sleep, and stress responses. When Menin levels fall with age, the resulting neuroinflammation appears to ripple outward, affecting skin, bone, and cognitive function simultaneously. A landmark 2023 study published in PLOS Biology by Lige Leng and colleagues at Xiamen University demonstrated that restoring Menin in elderly mice reversed several of these changes within just 30 days, sparking significant interest in whether this pathway could one day be targeted in humans.

Before diving deeper, here is a side-by-side summary of what the research has shown across the key outcomes studied:

Outcome	Menin Knockout (young mice)	Menin Restoration (elderly mice, 30 days)	D-Serine Supplementation Alone (3 weeks)
Skin thickness	Reduced (thinning)	Improved	No significant change
Bone mass	Reduced	Improved	No significant change
Cognitive performance	Declined	Improved	Improved
Hypothalamic inflammation	Increased	Reduced	Not fully reversed
D-serine (hippocampus)	Decreased	Increased	Increased (directly)
Lifespan (mice)	Modestly shortened	Extended	Not reported

This table captures the central finding: Menin restoration produced broad, body-wide effects, while D-serine supplementation alone addressed cognition but left physical aging markers — including skin thinning — largely untouched.

What exactly is Menin, and where does it come from?

Menin is a multifunctional nuclear protein encoded by the MEN1 tumor suppressor gene. It is best known in oncology as a regulator of cell growth — mutations in MEN1 cause multiple endocrine neoplasia type 1, a hereditary condition involving tumors of the parathyroid, pituitary, and pancreas. Its role in aging research is newer and distinct from its cancer biology.

In the context of aging, Menin's relevance lies in its ability to restrain neuroinflammatory signaling in the hypothalamus. The hypothalamus matters for many aspects of healthy aging — metabolic and cognitive health, the stress response, circadian rhythm maintenance — as Dr. Ashley E. Webb of Brown University noted when commenting on the research. When Menin is present at adequate levels, it helps keep inflammation in check. When it declines, that brake is released.

The Xiamen University team found that Menin levels dropped specifically in neurons within the ventromedial hypothalamus (VMH) — a subregion tied to metabolism and systemic aging — as mice grew older. The decline was not seen in astrocytes or microglia, the brain's support and immune cells. This cell-type specificity suggests the loss is not a general feature of brain aging but something happening in a particular neuronal population, which could eventually make it a more precise therapeutic target.

How does Menin loss lead to thinner skin and weaker bones?

The connection between a brain protein and the skin might seem counterintuitive, but it fits within a broader framework: the hypothalamus as a central regulator of systemic aging. When Menin levels fall in VMH neurons, hypothalamic neuroinflammation increases, and this inflammation appears to propagate signals that affect peripheral tissues — including the dermis.

To confirm that Menin loss causes aging rather than merely accompanying it, the researchers created conditional knockout mice — animals genetically engineered so Menin could be selectively removed. Reducing Menin in younger mice produced a striking cluster of aging-related changes: reduced skin thickness, lower bone mass, smaller muscle fiber size, impaired tail tendon collagen cross-linking, cognitive decline, and a modestly shortened lifespan. These are not subtle statistical signals — they are the hallmarks of accelerated biological aging appearing in animals that were not yet old.

For skin specifically, the thinning observed in Menin-knockout mice mirrors what happens naturally in aged skin: the dermis loses collagen density, the epidermis thins, and structural integrity declines. The fact that this could be induced by removing a single brain protein — and reversed by restoring it — points to a neuroendocrine axis that skin researchers have not traditionally focused on. If you are interested in how collagen-related pathways are targeted topically, our guide to best plumping and collagen-boosting serums covers the surface-level options currently available, but the Menin research suggests the upstream signal may originate far deeper, in the brain itself.

What is D-serine, and why does Menin affect it?

D-serine is a naturally occurring amino acid that acts as a co-agonist at NMDA receptors — the receptors responsible for synaptic plasticity, the process by which neurons strengthen or weaken connections to encode memories. Unlike its mirror image L-serine, which is the form found in dietary proteins and most foods, D-serine is synthesized in the brain by an enzyme called serine racemase.

The Menin–D-serine link is mechanistic: Menin regulates the activity of serine racemase. When Menin levels fall, serine racemase becomes less active, D-serine production drops, and NMDA receptor signaling weakens — contributing to the memory and learning deficits seen in aged animals. Restoring Menin in elderly mice raised D-serine levels in the hippocampus, the brain's memory hub, alongside the cognitive improvements.

An important distinction gets lost in popular coverage of this research: D-serine is not the same as the serine found in soybeans, eggs, fish, and nuts. Those foods contain L-serine. The body can convert L-serine to D-serine, but eating protein-rich foods is not equivalent to the experimental D-serine treatment used in these studies. Giving aged mice D-serine in their drinking water for three weeks improved cognitive performance, but it did not reproduce the broader improvements in skin thickness or bone mass seen after Menin restoration. D-serine addressed one downstream effect; Menin restoration addressed the upstream cause.

Did restoring Menin actually reverse skin aging in mice?

Yes — within the limits of what mouse studies can demonstrate. When the researchers delivered the Menin gene directly into the hypothalamus of 20-month-old mice (roughly equivalent to late-life aging in humans), 30 days later the treated animals showed improved skin thickness and bone mass, alongside better performance on tests of learning, cognition, and balance. The improvements correlated with higher D-serine levels in the hippocampus and reduced hypothalamic inflammation.

Lead researcher Lige Leng described the significance this way: "We speculate that the decline of Menin expression in the hypothalamus with age may be one of the driving factors of aging, and Menin may be the key protein connecting the genetic, inflammatory, and metabolic factors of aging."

The study also reported extended lifespan in Menin-restored mice, though the magnitude of that extension and the precise mechanisms remain to be fully characterized. What makes the skin finding particularly notable is that it emerged from a brain intervention — no topical treatment, no dermal injection, no systemic drug targeting the skin directly. The signal traveled from the hypothalamus outward.

What has subsequent research added to the picture?

The original 2023 findings have been followed by several related studies that deepen — and complicate — the picture.

A March 2024 study in the Journal of Physiology and Biochemistry examined Menin in cultured mouse hippocampal cells exposed to corticosterone, a stress hormone. A compound called itaconate increased Menin levels, reduced inflammation, and reduced a form of cell death. When researchers silenced Menin, that protection disappeared. This was a cell study, not an animal aging experiment, but it supported a protective role for Menin in a different experimental context.

In January 2025, an Allen Institute team published an analysis of roughly 1.2 million mouse brain cells in Nature, finding that some of the cell types most sensitive to aging were concentrated around the hypothalamus's third ventricle. Many showed reduced activity in genes associated with neuronal function and increased activity in immune-response genes — a pattern consistent with the neuroinflammation story Menin research has been building.

A 2024 Cell Metabolism study at Washington University School of Medicine identified a different group of hypothalamic neurons that communicates with fat tissue; maintaining this system increased physical activity and extended lifespan in mice. The molecular pathway was distinct from Menin, but it reinforced the broader idea that the brain actively regulates aging throughout the body.

The D-serine story also grew more complicated. An April 2025 study in Cellular and Molecular Life Sciences examined mice engineered to develop Alzheimer's-like features and found that an early rise in D-serine accompanied disruptions in brain signaling — and that genetically removing the enzyme that produces D-serine actually prevented some later cognitive problems. A September 2026 study in the Journal of Alzheimer's Disease found that an L-serine-enriched diet partially restored new neuron production in the hippocampus of a different Alzheimer's model, without improving amyloid buildup. These findings do not overturn the Menin results, but they make clear that serine metabolism is context-dependent: more is not always better, and the form, the disease model, and the outcome all matter.

Is there any human evidence for Menin or D-serine in aging?

Human evidence is thin. A small randomized study published in 2016 — before the Menin work — tested a single dose of D-serine in 50 healthy older adults. Participants improved on one measure of a computerized maze task, but showed no significant benefit on other cognitive tests or mood measures. The experiment did not establish lasting memory benefits, slower aging, or the safety of prolonged use in older adults.

No human trials have tested Menin restoration. The gene delivery approach used in mice — injecting a viral vector carrying the Menin gene into a specific hypothalamic subregion — is a technically demanding intervention that would require extensive safety evaluation before human application. Dr. Santosh Kesari, director of Neuro-oncology at the Pacific Neuroscience Institute, told Medical News Today that he believes much of the biology will extrapolate to humans, but noted that further studies are needed to confirm this.

The honest summary: compelling mouse data, no confirmed human aging benefit, and several open questions about mechanism, safety, and durability.

Why does the hypothalamus matter so much for aging research?

The hypothalamus is a small diencephalic brain region — the primary interface between the nervous system and the endocrine system — regulating hunger, thirst, temperature, sleep, stress responses, and reproductive function. Its role as a potential "aging clock" has gained traction over the past decade.

The Menin findings fit within this larger framework. Researchers increasingly view the hypothalamus as a central command center for aging itself, with inflammation in this region propagating dysfunction across multiple organ systems. The hypothalamus influences the autonomic nervous system and hormones to regulate heart rate, blood pressure, immune function, and circadian rhythms — all of which deteriorate with age. If a single protein like Menin can modulate the inflammatory tone of this region, it becomes a plausible intervention point for systemic effects.

This is why the skin findings are not as surprising as they first appear. Skin aging is not purely a local process. Hormonal changes, systemic inflammation, and metabolic shifts all contribute to the thinning dermis, reduced collagen synthesis, and impaired barrier function that characterize aged skin. A brain-originating signal that drives hypothalamic inflammation could plausibly accelerate all of these processes simultaneously — and reversing that signal could slow them.

What does this mean for people interested in skin and hair aging?

For anyone tracking the science of skin aging, the Menin research represents a genuinely novel angle: the idea that some of what we see in the mirror may be downstream of neuroinflammatory changes in the brain. This does not mean topical skincare is irrelevant — far from it. Ingredients that support collagen, barrier function, and antioxidant defense still do meaningful work at the skin surface. But it raises the possibility that future anti-aging strategies might target the neuroendocrine axis rather than — or in addition to — the skin directly.

For hair, the connection is more speculative. Hypothalamic signaling influences hormonal axes known to affect hair cycling, including growth hormone and sex hormone pathways. Whether Menin specifically plays a role in hair follicle aging has not been studied, but the broader principle — that brain-originating inflammation can accelerate peripheral tissue aging — is worth watching. Our coverage of amino acid scalp shampoos and Japanese hair growth serums focuses on what is available and evidence-supported today; the Menin pathway represents where research may be heading.

Practically speaking, there is nothing a consumer can currently do to directly target Menin. D-serine supplements exist, but evidence that they reverse physical aging in humans is absent, and the Alzheimer's research suggests that indiscriminate D-serine elevation carries its own risks depending on the underlying biology. A diet supporting general protein synthesis — including L-serine-containing foods like eggs, fish, soybeans, and nuts — is reasonable, but should not be marketed as a Menin-pathway intervention.

What are the key open questions?

Several important unknowns remain before this research can inform clinical practice.

What causes Menin to decline with age in the first place? The study identified the consequences of that decline but not the upstream trigger. Understanding the cause could reveal whether lifestyle factors — chronic stress, sleep disruption, inflammatory diet — accelerate Menin loss, and whether modifying them could slow it.

How durable are the benefits of Menin restoration? The mouse experiments measured outcomes at 30 days post-intervention. Whether the improvements persist, plateau, or require repeated dosing is unknown.

Can the intervention be delivered safely in humans? Hypothalamic gene delivery is not a trivial procedure. The VMH is a small, deep brain structure, and off-target effects of Menin manipulation — given its role in tumor suppression — would need careful evaluation.

Does Menin decline occur in human hypothalamic neurons in the same pattern as in mice? Postmortem human brain studies examining Menin expression across age groups would be a logical next step.

The central possibility, as the researchers framed it, remains compelling: some changes associated with aging — including skin thinning — may be influenced by signals originating in a small part of the brain. Understanding those signals could eventually reveal ways to protect function later in life. For now, the evidence points to an experimental pathway worth investigating, not a supplement or treatment proven to turn back human aging.